Merouane Bencherif
Plus aucun poste en cours
Profil
Merouane Bencherif is the founder of Targacept, Inc. which was founded in 1997.
He held the title of Senior Vice President-Preclinical Research from 2010 to 2014.
Dr. Bencherif has a doctorate degree from the University of Virginia and the University of Algiers Medical School.
He also has an undergraduate degree from Université d'Aix-Marseille.
Anciens postes connus de Merouane Bencherif
| Sociétés | Poste | Fin |
|---|---|---|
Targacept, Inc.
 Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | Fondateur | - |
Formation de Merouane Bencherif
| University of Virginia | Doctorate Degree |
| Université d'Aix-Marseille | Undergraduate Degree |
| University of Algiers Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | Health Technology |
